Article info
Basic and translational research
Extended report
Mesenchymal stem cell therapy in proteoglycan induced arthritis
- Correspondence to Joost F Swart, Department of Pediatric Immunology and Laboratory of Translational Immunology, Center for Molecular and Cellular Intervention (CMCI), Wilhelmina Children's Hospital, University Medical Center Utrecht, KC 03.063.0, PO Box 85090, Utrecht 3508 AB, The Netherlands; jswart{at}umcutrecht.nl
Citation
Mesenchymal stem cell therapy in proteoglycan induced arthritis
Publication history
- Received June 20, 2013
- Revised November 23, 2013
- Accepted December 14, 2013
- First published January 6, 2014.
Online issue publication
March 05, 2015
Article Versions
- Previous version (6 January 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions